Chateau Pichon-Longueville Baron Pauillac 2009
Planted to 60% Cabernet Sauvignon, 35% Merlot, 4% Cabernet Franc and 1% Petit Verdot, the 2nd Growth estate of Pichon-Baron, has vines which average 30+ years. The property consistently produces top flight wines, and is often referred to as a 'super-second' performing well above its official pedigree. Located across from Chateau Latour and Chateau Pichon Longueville Comtesse de Lalande, the vineyard is superbly situated on gravelly soil with a full southerly exposure, and much of the vineyard is adjacent to that of Chateau Latour. AXA smarlty hired Jean-Michel Cazes of Lynch-Bages to oversee the vineyard and winemaking in the early 1980s through 2000 which initiated a quality renaissance that continues today.
|Brand||Chateau Pichon-Longueville Baron|
Wine AdvocateRevealing incredible quality and performing better than it did from barrel, the 2009 appears to be the greatest Pichon Longueville Baron since the 1990 and 1989. An amazing opaque blue/purple color is followed by scents of spring flowers, graphite, smoky charcoal, incense, blackberries, blueberries and hints of coffee and chocolate. Incredibly intense, pure and flawlessly constructed with extravagant layers of fruit and richness, this offering has developed beautifully under the management of Christian Seeley. It is a voluptuous, opulent Pichon Longueville Baron that may eclipse anything they have made in the past. This brilliant wine should be at its peak between 2018 and 2045.
Wine EnthusiastWith a structure that runs between acidity and dark smoky tannins, this is a wine with potential opulence. It's very rich in character, dense and dark. The black plum flavors are dominant, along with excellent acidity. For the long-term.
Wine SpectatorThis delivers a massive core of black Mission fig, black currant paste and roasted fig fruit, backed by alder wood, bay leaf, singed cedar and maduro tobacco. The finish lets a racy iron note take over. Long and authoritative, with gorgeous acidity giving the balance for long-term cellaring. Best from 2013 through 2030. 13,000 cases made.